# Vanderbilt University Spasticity Management Program Evaluation Plan

> **NCT00179114** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 20 (—)

## Conditions studied

- Spasticity

## Interventions

- **DRUG:** Botulinum Toxin Type A
- **DRUG:** Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)

## Key facts

- **NCT ID:** NCT00179114
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 20 (—)
- **Last updated:** 2007-08-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00179114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00179114, "Vanderbilt University Spasticity Management Program Evaluation Plan". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00179114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*